Rationally synthesized coumarin based pyrazolines ameliorate carrageenan induced inflammation through COX-2/pro-inflammatory cytokine inhibition. Issue 3 (7th February 2019)

• Record Type: Journal Article
• Authors: Chandel, Priyanka; Kumar, Anoop; Singla, Nishu; Kumar, Anshul; Singh, Gagandeep; Gill, Rupinder Kaur
• Is Part Of: MedChemComm. Volume 10:Issue 3(2019)
• Page Start: 421
• Page End: 430
• Publication Date: 2019-02-07
• Subjects: Pharmaceutical chemistry -- Periodicals; 615.19
• DOI: 10.1039/c8md00457a
• Languages: English
• ISSNs: 2040-2503

Abstract

Abstract : In the present work, coumarin based pyrazolines (7a–g ) have been synthesized and investigated for their in vitro and in vivo anti-inflammatory potential. Abstract : In the present work, coumarin based pyrazolines (7a–g ) have been synthesized and investigated for their in vitro and in vivo anti-inflammatory potential. Amongst the synthesized compounds, compounds7a, 7d and7f exhibited significant in vitro anti-inflammatory activity as compared to the standard etoricoxib. Keeping this in mind, in vivo investigations were carried out via carrageenan induced inflammation and acetic acid induced writhing models in male Wistar rats and compound7a was found to possess appreciable anti-inflammatory and analgesic potential. The mode of action of compound7a was also investigated by using substance P as the biomarker, which shows promising results. Further, the selectivity of the most active compound7a against the cyclooxygenase enzyme was supported by molecular docking studies which reveal that compound7a has greater binding affinity towards COX-2 over COX-1 and 5-LOX enzymes. In silico ADME analysis of compound7a confirms the drug-like characteristics and the in vivo acute toxicity study showed the safety of the compound even up to a 2000 mg kg −1 dose. Thus, compound7a was identified as an effective anti-inflammatory agent, and can be explored for further analgesic/anti-inflammatory drug design and development.